Evidence map›Paper›PMID 31847432›Full record

ReviewSensors (Basel, Switzerland)2019

Gaze and Eye Tracking: Techniques and Applications in ADAS.

Muhammad Qasim Khan, Sukhan Lee

Open access · goldAbstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Effect of CannEpilJournal of psychopharmacology (Oxford, England) · 2023
    Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Muhammad Qasim KhanDepartment of Electrical and Computer Engineering, Intelligent Systems Research Institute, Sungkyunkwan University, Suwon 440-746, Korea.
Sukhan LeeDepartment of Electrical and Computer Engineering, Intelligent Systems Research Institute, Sungkyunkwan University, Suwon 440-746, Korea.
Sungkyunkwan University · KR

Funding

Korea Institute of Energy Technology Evaluation and Planning KETEP 20172010000420
6 · The paper itself

Abstract

Tracking drivers' eyes and gazes is a topic of great interest in the research of advanced driving assistance systems (ADAS). It is especially a matter of serious discussion among the road safety researchers' community, as visual distraction is considered among the major causes of road accidents. In this paper, techniques for eye and gaze tracking are first comprehensively reviewed while discussing their major categories. The advantages and limitations of each category are explained with respect to their requirements and practical uses. In another section of the paper, the applications of eyes and gaze tracking systems in ADAS are discussed. The process of acquisition of driver's eyes and gaze data and the algorithms used to process this data are explained. It is explained how the data related to a driver's eyes and gaze can be used in ADAS to reduce the losses associated with road accidents occurring due to visual distraction of the driver. A discussion on the required features of current and future eye and gaze trackers is also presented.

Indexed as

Automobile DrivingAccidents, TrafficAlgorithmsEye MovementsHumansadvanced driving assistance systems (ADAS)eye trackinggaze trackingline of sight (LoS)point of regard (PoR)road safety

Identifiers

PMID31847432
PMCPMC6960643
OpenAlexW2995733078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.